scorecardresearch
Friday, March 29, 2024
TopicIndian drugs

Topic: Indian drugs

ICMR calls for development of local drugs for rare diseases, offers assistance in clinical research

The medical research body aims to encourage domestic companies to develop cost-effective treatments for rare conditions, such as spinal muscular atrophy, Gaucher disease, among others.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Regulatory actions taken against 105 pharma companies, says health minister Mansukh Mandaviya

The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas.

WHO says 20 ‘contaminated’ drugs from Indian & Indonesian makers under scanner

WHO spokesperson says instances of contaminated drugs being found in 6 countries warranted Medical Product Alerts & that it takes reports of substandard medical products seriously.

‘Feeding cough syrup seems like Russian roulette’—new book exposes drug regulation in India

Dinesh S. Thakur and Prashant Reddy tapped into the nitty gritty of drug regulation, cough syrups and medicines in India at the launch of their book ‘Truth Pill’ in Delhi.

How Delhi Police’s war against drugs saved India from becoming another Colombia

In ‘Khaki in Dust Storm’, former DGP Amod K. Kanth revisits the 1980s and 1990s when India witnessed riots, political assassinations & growing culture of drug abuse.

Trump’s ‘Buy American First’ order will actually favour India — drug export body tells govt

Pharmexcil has told Modi govt that Indian generics constitute 10% of the US generic market in value terms & the order may give Indian drugmakers a chance to capture more.

Modi govt plans action against US writer who said Indian drugs are ‘flea-market quality’

In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.  

To fight China monopoly, Modi govt to speed up approvals for 4 mega bulk drugs parks

Bulk drugs are raw materials for the manufacture of drugs, and Indian drug makers import around 70% of their total requirement from China.

US censures Gujarat-based Torrent Pharma for inferior quality medicines

In a strongly-worded letter, US Food and Drug Administration has accused Torrent of ‘repeating the failures and lacking control over the manufacture of drugs’.

On Camera

Oka to Nagarathna—Bombay High Court judges taking up the cudgel when faith in courts eroding

When lynching, hate speech and bulldozer politics do not speedily invite the wrath of courts, then something is wrong with the third pillar of governance.

Congress attacks chief economic advisor over statement on unemployment, asks BJP govt to ‘vacate seat’

While releasing 'India Employment Report 2024', V Anantha Nageswaran said govt can't solve 'all social, economic challenges'. Congress leader Kharge says CEA protecting 'dear leader'.

Amid plans to lift AFSPA, Army starts joint training with Jammu & Kashmir Police

In an interview with Gulistan News this week, Union Home Minister Amit Shah said the government would leave law and order to J&K Police and slowly withdraw troops.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.